<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0015157"><a href="http://purl.obolibrary.org/obo/MONDO_0015157">MONDO:0015157</a></h3>
<p><strong>Label:</strong> human herpesvirus 8-related disorder</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0015564">MONDO:0015564</a> (Castleman disease), <a href="http://purl.obolibrary.org/obo/MONDO_0018049">MONDO:0018049</a> (Kaposi sarcoma), <a href="http://purl.obolibrary.org/obo/MONDO_0019754">MONDO:0019754</a> (multicentric Castleman disease),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_33276">Orphanet:33276</a>, <a href="http://www.orpha.net/ORDO/Orphanet_160">Orphanet:160</a>, <a href="http://www.orpha.net/ORDO/Orphanet_93686">Orphanet:93686</a>, <a href="http://purl.obolibrary.org/obo/OMIM_148000">OMIM:148000</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0200036">HP:0200036</a> (Skin nodule) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0200035">HP:0200035</a> (Skin plaque) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0200034">HP:0200034</a> (Papule) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0100742">HP:0100742</a> (Vascular neoplasm) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0040064">HP:0040064</a> (Abnormality of limbs) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0030680">HP:0030680</a> (Abnormality of cardiovascular system morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0025142">HP:0025142</a> (Constitutional symptom) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0025015">HP:0025015</a> (Abnormal vascular morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0012733">HP:0012733</a> (Macule) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0012378">HP:0012378</a> (Fatigue) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0011355">HP:0011355</a> (Localized skin lesion) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0011123">HP:0011123</a> (Inflammatory abnormality of the skin) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0011122">HP:0011122</a> (Abnormality of skin physiology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008940">HP:0008940</a> (Generalized lymphadenopathy) and <a href="http://purl.obolibrary.org/obo/HP_0011121">HP:0011121</a> (Abnormality of skin morphology) 62.50%</li>
</ul>
</body>
</html>
